New obesity drug combo tested against diet in metabolism showdown
NCT ID NCT07184086
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looks at how a new investigational medicine called CagriSema affects the body's energy use compared to a calorie-reduced diet. About 80 adults with obesity will be randomly assigned to either CagriSema or a weight-loss diet for the first part, then everyone gets CagriSema. The goal is to measure changes in how the body burns energy at rest and over 24 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advent Health-Res Inst
RECRUITINGOrlando, Florida, 32804, United States
-
Pennington Biomed Res Ctr
RECRUITINGBaton Rouge, Louisiana, 70808-4124, United States
Conditions
Explore the condition pages connected to this study.